Independent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 190, Issue 7, 2013, Pages 3225-3234

  Fitzgerald, Denise C ^a   Fonseca Kelly, Zoë ^b   Cullimore, Melissa L ^c   Safabakhsh, Pegah ^c   Saris, Christiaan J M ^d   Zhang, Guang Xian ^c   Rostami, Abdolmohamad ^c,e  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d AMGEN INC   (United States)

^e THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 27;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH17 CELL; UPREGULATION;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; INTERLEUKIN-10; INTERLEUKINS; MICE; MONOCYTES; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84875447284     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200141     Document Type: Article

References (44)

1. Villarino, A. V., E. Huang, and C. A. Hunter. 2004. Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 173: 715-720.
2. Pflanz, S., J. C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert, T. Churakova, M. Travis, E. Vaisberg, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16: 779-790.
3. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
4. Niedbala, W., X. Q. Wei, B. Cai, A. J. Hueber, B. P. Leung, I. B. McInnes, and F. Y. Liew. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37: 3021-3029.
5. Fitzgerald, D. C., B. Ciric, T. Touil, H. Harle, J. Grammatikopolou, J. Das Sarma, B. Gran, G. X. Zhang, and A. Rostami. 2007. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 179: 3268-3275.
6. Li, J., B. Gran, G. X. Zhang, A. Rostami, and M. Kamoun. 2005. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J. Neurol. Sci. 232: 3-9.
7. Smits, H. H., A. J. van Beelen, C. Hessle, R. Westland, E. de Jong, E. Soeteman, A. Wold, E. A. Wierenga, and M. L. Kapsenberg. 2004. Commensal Gramnegative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur. J. Immunol. 34: 1371-1380.
8. Sonobe, Y., I. Yawata, J. Kawanokuchi, H. Takeuchi, T. Mizuno, and A. Suzumura. 2005. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 1040: 202-207.
9. Stumhofer, J. S., A. Laurence, E. H. Wilson, E. Huang, C. M. Tato, L. M. Johnson, A. V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7: 937-945.
10. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. A. Kastelein, C. Saris, and C. A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655.
11. Pflanz, S., L. Hibbert, J. Mattson, R. Rosales, E. Vaisberg, J. F. Bazan, J. H. Phillips, T. K. McClanahan, R. de Waal Malefyt, and R. A. Kastelein. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172: 2225-2231.
12. Batten, M., J. Li, S. Yi, N. M. Kljavin, D. M. Danilenko, S. Lucas, J. Lee, F. J. de Sauvage, and N. Ghilardi. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7: 929-936.
13. Yoshimura, T., A. Takeda, S. Hamano, Y. Miyazaki, I. Kinjyo, T. Ishibashi, A. Yoshimura, and H. Yoshida. 2006. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177: 5377-5385.
14. Awasthi, A., Y. Carrier, J. P. Peron, E. Bettelli, M. Kamanaka, R. A. Flavell, V. K. Kuchroo, M. Oukka, and H. L. Weiner. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8: 1380-1389.
15. Batten, M., N. M. Kljavin, J. Li, M. J. Walter, F. J. de Sauvage, and N. Ghilardi. 2008. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180: 2752-2756.
16. Fitzgerald, D. C., G. X. Zhang, M. El-Behi, Z. Fonseca-Kelly, H. Li, S. Yu, C. J. Saris, B. Gran, B. Ciric, and A. Rostami. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8: 1372-1379.
17. Stumhofer, J. S., J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris, L. A. Turka, M. Ernst, C. J. Saris, J. J. O'Shea, and C. A. Hunter. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8: 1363-1371.
18. Ramgolam, V. S., Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese. 2009. IFN-β inhibits human Th17 cell differentiation. J. Immunol. 183: 5418-5427.
19. Tuohy, V. K., M. Yu, L. Yin, P. M. Mathisen, J. M. Johnson, and J. A. Kawczak. 2000. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. J. Neuroimmunol. 111: 55-63.
20. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
21. Buttmann, M., and P. Rieckmann. 2007. Interferon-β1b in multiple sclerosis. Expert Rev. Neurother. 7: 227-239.
22. Paolicelli, D., V. Direnzo, and M. Trojano. 2009. Review of interferon β-1b in the treatment of early and relapsing multiple sclerosis. Biologics 3: 369-376.
23. Waubant, E., L. Gee, P. Bacchetti, R. Sloan, A. Cotleur, R. Rudick, and D. Goodkin. 2001. Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. J. Neuroimmunol. 112: 139-145.
24. Kikly, K., L. Liu, S. Na, and J. D. Sedgwick. 2006. The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18: 670-675.
25. Galligan, C. L., L. M. Pennell, T. T. Murooka, E. Baig, B. Majchrzak-Kita, R. Rahbar, and E. N. Fish. 2010. Interferon-b is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis. Mult. Scler. 16: 1458-1473.
26. Murugaiyan, G., A. Mittal, R. Lopez-Diego, L. M. Maier, D. E. Anderson, and H. L. Weiner. 2009. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J. Immunol. 183: 2435-2443.
27. Neufert, C., C. Becker, S. Wirtz, M. C. Fantini, B. Weigmann, P. R. Galle, and M. F. Neurath. 2007. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur. J. Immunol. 37: 1809-1816.
28. Chen, M., G. Chen, H. Nie, X. Zhang, X. Niu, Y. C. Zang, S. M. Skinner, J. Z. Zhang, J. M. Killian, and J. Hong. 2009. Regulatory effects of IFN-β on production of osteopontin and IL-17 by CD4+ T cells in MS. Eur. J. Immunol. 39: 2525-2536.
29. Ramgolam, V. S., Y. Sha, K. L. Marcus, N. Choudhary, L. Troiani, M. Chopra, and S. Markovic-Plese. 2011. B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis. J. Immunol. 186: 4518-4526.
30. Zhang, X., J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese. 2009. IFN-β1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J. Immunol. 182: 3928-3936.
31. Rudick, R. A., R. M. Ransohoff, R. Peppler, S. VanderBrug Medendorp, P. Lehmann, and J. Alam. 1996. Interferon β induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol. 40: 618-627.
32. Zhang, L., S. Yuan, G. Cheng, and B. Guo. 2011. Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS ONE 6: e28432.
33. Sweeney, C. M., R. Lonergan, S. A. Basdeo, K. Kinsella, L. S. Dungan, S. C. Higgins, P. J. Kelly, L. Costelloe, N. Tubridy, K. H. Mills, and J. M. Fletcher. 2011. IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav. Immun. 25: 1170-1181.
34. Axtell, R. C., B. A. de Jong, K. Boniface, L. F. van der Voort, R. Bhat, P. De Sarno, R. Naves, M. Han, F. Zhong, J. G. Castellanos, et al. 2010. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16: 406-412.
35. Wender, M., S. Michalak, and H. Wygladalska-Jernas. 2001. The effect of shortterm treatment with interferon β1a on acute experimental allergic encephalomyelitis. Folia Neuropathol. 39: 91-93.
36. Yasuda, C. L., A. Al-Sabbagh, E. C. Oliveira, B. M. Diaz-Bardales, A. A. Garcia, and L. M. Santos. 1999. Interferon β modulates experimental autoimmune encephalomyelitis by altering the pattern of cytokine secretion. Immunol. Invest. 28: 115-126.
37. Yu, M., A. Nishiyama, B. D. Trapp, and V. K. Tuohy. 1996. Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J. Neuroimmunol. 64: 91-100.
38. Guo, B., E. Y. Chang, and G. Cheng. 2008. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 118: 1680-1690.
39. Anderson, C. F., J. S. Stumhofer, C. A. Hunter, and D. Sacks. 2009. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J. Immunol. 183: 4619-4627.
40. Hedrich, C. M., A. Ramakrishnan, D. Dabitao, F. Wang, D. Ranatunga, and J. H. Bream. 2010. Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4+ T cell activation; influence of IL-27. Mol. Immunol. 48: 73-81.
41. El-behi, M., B. Ciric, S. Yu, G. X. Zhang, D. C. Fitzgerald, and A. Rostami. 2009. Differential effect of IL-27 on developing versus committed Th17 cells. J. Immunol. 183: 4957-4967.
42. Stromnes, I. M., L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman. 2008. Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells. Nat. Med. 14: 337-342.
43. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
44. Weber, M. S., and B. Hemmer. 2010. Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis. Results Probl. Cell Differ. 51: 115-126.